Colon cancer is one of the most common forms of cancer in the United States, and it is estimated that more than 140,000 people will be diagnosed with the disease this year. While the overall survival rate for colon cancer has improved over the years, new therapies are helping to dramatically improve the chances of survival for those diagnosed with the disease.
Recent advances in medical technology have allowed for more precise and targeted treatments for colon cancer. For example, immunotherapy is a type of treatment that uses the body’s own immune system to fight cancer cells. This type of therapy has been shown to be effective in treating colon cancer, and it has been associated with improved survival rates.
In addition, targeted therapies are being used to treat colon cancer. These therapies are designed to target specific genes or proteins that are associated with the disease. By targeting these genes or proteins, doctors can more effectively treat the cancer and improve the chances of survival.
Finally, new treatments such as chemotherapy and radiation therapy are being used to treat colon cancer. These treatments are designed to kill cancer cells and reduce the size of tumors. While these treatments can be difficult to endure, they can be effective in treating the disease and improving the chances of survival.
Overall, the survival rate for colon cancer has improved dramatically in recent years due to advances in medical technology and treatments. Immunotherapy, targeted therapies, and chemotherapy and radiation therapy are all helping to improve the chances of survival for those diagnosed with the disease. With continued research and advances in medical technology, the survival rate for colon cancer is likely to continue to improve in the years to come.